AlexLMX/iStock via Getty Images
ANI Pharmaceuticals (ANIP) is a company I have owned off and on the last three months. The enterprise has made a number of small deals to acquire existing drugs patents, some production assets, and the potential for new pharma…
A Low Valuation, High Growth Target: ANI Pharmaceuticals
Share this article
More News




Why Trump backed a crypto ethics rule that stopped at the family business
September 19, 2026



Nasdaq (NDAQ) Just Made It Harder For Crypto Criminals To Hide
September 19, 2026